Minnesota’s CVRx Receives FDA Approval for World’s First Heart Failure Neuromodulation Device

sourced

Categories

Via News Release

CVRxMINNEAPOLISAug. 16, 2019 /PRNewswire/ — CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug Administration (FDA) to market its BAROSTIM NEO device for heart failure in the United States. The FDA’s Center for Devices and Radiological Health (CDRH) approved the Company’s submission after a thorough review of the clinical trial data from the Baroreflex Activation Therapy for Heart Failure Pivotal Trial (BeAT-HF).

Read More »

POPS! Diabetes Care Announces Closing of Oversubscribed Series A Funding

by valerielockhart

Categories

Image result for pops diabetes care logoThe team at POPS! Diabetes Care, Inc. has plenty of reason to celebrate this summer. They recently closed an oversubscribed Series A funding of $6 Million, with incredible investor demand. Their product, a digital system which allows users to track and manage their A1C and insulin levels through an app and connected monitoring device, is making major waves in the healthcare space. FDA approval was reached in November of 2018, and in preliminary clinical research, their product demonstrated a 1-point drop in overall A1C for users.

Read More »

International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for Peripheral Vascular Disease

sourced

Categories

Via News Release

Image result for International Cardio CorporationMINNEAPOLIS–(BUSINESS WIRE)–International Cardio Corporation (ICC) announced today that it has achieved the first human use milestone of its HIFU Synthesizer™, a therapeutic ultrasound system designed to noninvasively treat vulnerable and occlusive plaques in peripheral arteries. The first of a fifteen patient Safety Study in the Netherlands, this achievement supports the company’s core objectives to reduce stroke mortality and improve the quality of life for those suffering from peripheral vascular disease (PVD).

Read More »

Cardiovascular Systems, Inc. Announces Former U.S. Congressman Erik Paulsen Joins Board of Directors

sourced

Categories

Via News Release

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Erik Paulsen. He replaces director Scott Bartos, who is retiring from the board after seven years of service. The CSI board continues to have seven directors, six of whom are independent.”

Read More »

Mayo Clinic, Boston Scientific Teaming Up on Med-tech Accelerator

sourced

Categories

Via Minneapolis/St. Paul Business Journal

Mayo Clinic and Boston Scientific Corp. on Monday will announce the formation of Motion Medical, a med-tech accelerator based near Mayo’s headquarters campus in Rochester, Minnesota.

In a statement, the organizations said Motion Medical would focus on development of new medical technology and minimally invasive treatments. The 1,800-square-foot facility will be located in One Discovery Square, the life-sciences research building that’s a key part of Rochester’s multibillion-dollar Destination Medical Center project.”

Read more…

Revel Announces Inaugural Healthcare Innovation Conference August 14-15, 2019

sourced

Categories

Via News Release

“MINNEAPOLISJuly 9, 2019 /PRNewswire/ — Representatives from Revel, a leading health action platform, announced Rev Up 2019, a new event to be held at the Hewing Hotel in downtown Minneapolis August 14-15, 2019. Rev Up 2019 is designed for change makers, innovators, and thought leaders passionate about making an impact in healthcare and eager to stay current with the changing healthcare landscape. The agenda for Rev Up 2019 will include forward-thinking keynote speakers, panel discussions, and sessions intended to generate healthy collaboration, spur new ideas, and change mindsets around creating healthier action for members, patients, and healthcare consumers in general.”

Read More »

Agiliti Acquires Zetta Medical Technologies

sourced

Categories

Via News Release

“MINNEAPOLIS–(BUSINESS WIRE)–Agiliti, Inc. (“Agiliti”), a leading, nationwide provider of healthcare technology management and service solutions, today announced it has acquired Zetta Medical Technologies, LLC (“Zetta”), a provider of medical imaging equipment services and parts, based in Lake Zurich, Ill.”

Read More »

Doctors Slow to Adopt Tech Tools that Might Save Patients Money on Drugs

sourced

Categories

Physicians complain that there's not yet a standard drug-pricing tool available to them that includes the range of medicine prices each of their patients might face — one that takes into account their particular pharmacy choice and health insurance plan.

Via MPR News, Phil Galewitz

“When Mary Kay Gilbert saw her doctor in May for a skin infection on her leg, she wasn’t surprised to receive a prescription for an antibiotic cream. But Gilbert, 54, a nurse and health consultant, was shocked when her physician clicked on the desktop computer and told Gilbert the medicine would cost $30 on her Blue Cross and Blue Shield plan. ‘I was like, “Wow — that’s pretty cool that you know that information,” ‘ she recalled telling the doctor in Edina, Minn.”

Read more…

Reprise Biomedical Raises $12.5 Million and Completes Spin-off From Miromatrix Medical

sourced

Via News Release

Reprise Biomedical.png“Minneapolis, Minn. (July 1, 2019) – Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology, has successfully completed a $12.5 million private placement and commenced operations as a spin-off from Miromatrix Medical Inc.”

Read More »

Post Navigation